Search

Natasha G Bolick

from Raleigh, NC
Age ~42

Natasha Bolick Phones & Addresses

  • 6023 Neuse Wood Dr, Raleigh, NC 27616 (919) 872-9135
  • 10812 Rio Bluff Dr, Raleigh, NC 27614 (919) 847-6306
  • Creedmoor, NC

Work

Company: Bd technologies 2010 to 2013 Address: Research Triangle Park, NC Position: Biomedical engineer

Education

School / High School: University of New South Wales 2000 to 2001

Industries

Medical Devices

Resumes

Resumes

Natasha Bolick Photo 1

Biomedical Engineer At Bd Technologies

View page
Position:
Biomedical Engineer at BD Technologies
Location:
Raleigh-Durham, North Carolina Area
Industry:
Medical Devices
Work:
BD Technologies - Research Triangle Park, NC since 2010
Biomedical Engineer
Education:
University of New South Wales 2000 - 2001
North Carolina State University 1995 - 1999

Publications

Us Patents

In Vivo Fluorescence Sensors, Systems, And Related Methods Operating In Conjunction With Fluorescent Analytes

View page
US Patent:
7778695, Aug 17, 2010
Filed:
Feb 19, 2009
Appl. No.:
12/389012
Inventors:
Robert D. Black - Chapel Hill NC,
Natasha Bolick - Creedmoor NC,
Assignee:
Sicel Technologies, Inc. - Morrisville NC
International Classification:
A61B 6/00
US Classification:
600476, 424 91, 424 96, 424426
Abstract:
Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stimulate toxin release based on the confirmation; and (h) monitor for the expression of a protein produced from a gene therapy modification. In particular embodiments, the intensity of the excitation signals emitted to the localized tissue can be varied in a predetermined manner to generate optical profiling data of the response of the tissue proximate the sensor.

In Vivo Fluorescence Sensors, Systems, And Related Methods Operating In Conjunction With Fluorescent Analytes

View page
US Patent:
2004019, Oct 7, 2004
Filed:
Feb 17, 2004
Appl. No.:
10/779907
Inventors:
Robert Black - Chapel Hill NC,
Natasha Bolick - Creedmoor NC,
International Classification:
A61K049/00
US Classification:
424/009600
Abstract:
Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stimulate toxin release based on the confirmation; and (h) monitor for the expression of a protein produced from a gene therapy modification. In particular embodiments, the intensity of the excitation signals emitted to the localized tissue can be varied in a predetermined manner to generate optical profiling data of the response of the tissue proximate the sensor.

Methods For Evaluating A Subject Using Data Associated With A Fluorescent Analyte

View page
US Patent:
2010029, Nov 25, 2010
Filed:
Jun 25, 2010
Appl. No.:
12/823858
Inventors:
Robert D. Black - Chapel Hill NC,
Natasha Bolick - Creedmoor NC,
International Classification:
A61B 5/1455
US Classification:
600310
Abstract:
Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from a sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stimulate toxin release based on the confirmation; and (h) monitor for the expression of a protein produced from a gene therapy modification.In particular embodiments, the intensity of the excitation signals emitted to the localized tissue can be varied in a predetermined manner to generate optical profiling data of the response of the tissue proximate the sensor.
Natasha G Bolick from Raleigh, NC, age ~42 Get Report